CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue
Research and development	€ 0	€ 0	€ 0	€ 3
Grants	103	297	377	779
Other	0	0	3	3
Total revenues	185	297	462	782
Expenses
Research and development	195	400	794	982
General and administrative	281	327	1,160	659
Total expenses	476	727	1,954	1,641
Operating Loss	(291)	(430)	(1,492)	(859)
Interest expense	711	699	1,408	1,393
Goodwill impairment	6,671	0	6,671	0
Other (income) expense	94	213	57	301
Operating expenses	7,394	912	8,054	1,694
Loss before income tax provision	(7,685)	(1,342)	(9,546)	(2,553)
Income tax provision	0	0	0	0
Net Loss	(7,685)	(1,342)	(9,546)	(2,553)
Other comprehensive income
Foreign currency translation adjustment	(9)	(2)	(9)	5
Comprehensive loss	€ (7,694)	€ (1,344)	€ (9,555)	€ (2,548)
Weighted-average shares outstanding, basic and diluted	303,757,622	303,757,622	303,757,622	303,757,622